Ellie Crabtree, 22, from Cumbria, fell into a trap of emotional eating while caring for her father, Geoff, 59, was diagnosed ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

The BOOST® Nutritional Drink brand unveiled today its new BOOST® Advanced Nutritional Shake designed to support nutritional ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China. Phase 2 data suggest ...

Vulnerable people have been warned about the emerging and potentially "devastating effects" of jabs used for weight loss.

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...

These five proven approaches, available through Excellus BlueCross BlueShield, can help you manage costs without compromising care.